šŗšøĀ·Jul 30Research
NCT07161037: Phase 2a Study of VX-407 in Participants With ADPKD Who Have a Subset of PKD1 Gene Variants (AGLOW)
Study type: INTERVENTIONAL. Phase: PHASE2.
Publisher
C
ClinicalTrials.gov
USA
This page provides a limited summary, publisher metadata, and related coverage to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- ClinicalTrials.gov
- Region
- USA
- Scope
- Research
- Published
- July 30, 2026
- Language
- EN
Publisher context, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Summary excerpt
Study type: INTERVENTIONAL. Phase: PHASE2.
Source route
Continue on clinicaltrials.gov
Leave the platform to read the original full article on the publisher site.
Source: ClinicalTrials.gov
Scope: Research
Related coverage
More related coverage
University of Minnesota/27m ago
Inside providersā efforts to turn military medics into new hires
University of Minnesota/27m ago
Most of Minnesotaās gray wolf pups donāt survive first year, but population remains stable
University of Minnesota/27m ago
āWe have more questions than answers on the impact of human health,ā Dr. Mary Kosuth on the findings of her microplastics research at the University of Minnesota
University of Minnesota/28m ago